Kite Pharma, Inc. Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 2,656 | 136,598 | 37,344 | |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 53.90 | 3,595 | 193,771 | 56,407 | |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 120.09 | 6,251 | 750,683 | 18,664 | 24.9 K to 18.7 K (-25.09 %) |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 2,656 | 136,598 | 24,915 | 22.3 K to 24.9 K (+11.93 %) |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 53.90 | 3,595 | 193,771 | 22,259 | 18.7 K to 22.3 K (+19.26 %) |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Option Exercise | M | 1.35 | 15,000 | 20,250 | 80,394 | |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 121.03 | 5,800 | 701,974 | 117,795 | 123.6 K to 117.8 K (-4.69 %) |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 120.52 | 9,200 | 1,108,784 | 123,595 | 132.8 K to 123.6 K (-6.93 %) |
| Aug 14 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Buy | M | 1.35 | 15,000 | 20,250 | 132,795 | 117.8 K to 132.8 K (+12.73 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 53.90 | 79,949 | 4,309,251 | 60,002 | |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 121.37 | 13,274 | 1,611,065 | 18,664 | 31.9 K to 18.7 K (-41.56 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 120.40 | 31,165 | 3,752,266 | 31,938 | 63.1 K to 31.9 K (-49.39 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 119.94 | 18,936 | 2,271,184 | 63,103 | 82 K to 63.1 K (-23.08 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 118.61 | 3,800 | 450,718 | 82,039 | 85.8 K to 82 K (-4.43 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 117.27 | 1,700 | 199,359 | 85,839 | 87.5 K to 85.8 K (-1.94 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 115.02 | 11,074 | 1,273,731 | 87,539 | 98.6 K to 87.5 K (-11.23 %) |
| Aug 10 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 53.90 | 79,949 | 4,309,251 | 98,613 | 18.7 K to 98.6 K (+428.36 %) |
| Aug 04 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Option Exercise | M | 44.91 | 6,000 | 269,460 | 146,000 | |
| Aug 04 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 110.05 | 5,131 | 564,667 | 49,400 | 54.5 K to 49.4 K (-9.41 %) |
| Aug 04 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 110.10 | 869 | 95,677 | 54,531 | 55.4 K to 54.5 K (-1.57 %) |
| Aug 04 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Buy | M | 44.91 | 6,000 | 269,460 | 55,400 | 49.4 K to 55.4 K (+12.15 %) |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Option Exercise | M | 44.91 | 3,000 | 134,730 | 152,000 | |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 109.35 | 321 | 35,101 | 49,400 | 49.7 K to 49.4 K (-0.65 %) |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 108.27 | 3,771 | 408,286 | 49,721 | 53.5 K to 49.7 K (-7.05 %) |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 107.58 | 5,431 | 584,267 | 53,492 | 58.9 K to 53.5 K (-9.22 %) |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Sell | S | 106.85 | 2,477 | 264,667 | 58,923 | 61.4 K to 58.9 K (-4.03 %) |
| Aug 03 2017 | KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Oper ... | Buy | M | 44.91 | 3,000 | 134,730 | 61,400 | 58.4 K to 61.4 K (+5.14 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 53.90 | 16,550 | 892,045 | 139,951 | |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 10,099 | 519,392 | 40,000 | |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 111.60 | 672 | 74,995 | 18,664 | 19.3 K to 18.7 K (-3.48 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 110.55 | 2,725 | 301,249 | 19,336 | 22.1 K to 19.3 K (-12.35 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 109.74 | 7,448 | 817,344 | 22,061 | 29.5 K to 22.1 K (-25.24 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 108.75 | 15,804 | 1,718,685 | 29,509 | 45.3 K to 29.5 K (-34.88 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 53.90 | 16,550 | 892,045 | 45,313 | 28.8 K to 45.3 K (+57.54 %) |
| Aug 01 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 10,099 | 519,392 | 28,763 | 18.7 K to 28.8 K (+54.11 %) |